Towards a reproducible protocol for repetitive and semi-quantitative rat brain imaging with 18 F-FDG: Exemplified in a memantine pharmacological challenge

NeuroImage

Volumn 96, Issue , 2014, Pages 276-287

  Deleye, Steven ^a   Verhaeghe, Jeroen ^a   wyffels, Leonie ^a,b   Dedeurwaerdere, Stefanie ^a   Stroobants, Sigrid ^a,b   Staelens, Steven ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Brain; Glucose; PET; Rat; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; MEMANTINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FOOD DEPRIVATION; FUNCTIONAL NEUROIMAGING; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RAT; REPRODUCIBILITY; STANDARD UPTAKE VALUE; WEIGHT CHANGE; ANIMAL; BIOLOGICAL MODEL; BRAIN; COMPUTER SIMULATION; DIAGNOSTIC USE; DRUG EFFECTS; IMAGE ENHANCEMENT; METABOLIC CLEARANCE RATE; METABOLISM; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; COMPUTER SIMULATION; FASTING; FLUORODEOXYGLUCOSE F18; IMAGE ENHANCEMENT; MALE; MEMANTINE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84899882305     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.04.004     Document Type: Article

References (50)

1. Lee K.H., Ko B.H., Paik J.Y., Jung K.H., Choe Y.S., Choi Y., Kim B.T. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice. J. Nucl. Med. 2005, 46(9):1531-1536. (Sep.).
2. Hosoi R., Matsumura A., Mizokawa S., Tanaka M., Nakamura F., Kobayashi K., Watanabe Y., Inoue O. MicroPET detection of enhanced 18F-FDG utilization by PKA inhibitor in awake rat brain. Brain Res. 2005, 1039(1):199-202. (Mar.).
3. Fueger B.J., Czernin J., Hildebrandt I., Tran C., Halpern B.S., Stout D., Phelps M.E., Weber W.A. Impact of animal handling on the results of 18F-FDG PET studies in mice. J. Nucl. Med. 2006, 47(6):999-1006. (Jun.).
4. Sung K.-K., Jang D.-P., Lee S., Kim M., Lee S.-Y., Kim Y.-B., Park C.-W., Cho Z.-H. Neural responses in rat brain during acute immobilization stress: a [F-18]FDG micro PET imaging study. Neuroimage 2009, 44(3):1074-1080. (Feb.).
5. Wong K.P., Sha W., Zhang X., Huang S.C. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice. J. Nucl. Med. 2011, 52(5):800-807. (May).
6. Jang D.-P., Lee S.-H., Park C.-W., Lee S.-Y., Kim Y.-B., Cho Z.-H. Effects of fluoxetine on the rat brain in the forced swimming test: a [F-18]FDG micro-PET imaging study. Neurosci. Lett. 2009, 451(1):60-64. (Feb.).
7. Backes H., Walberer M., Endepols H., Neumaier B., Graf R., Wienhard K., Mies G. Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using (18)F-FDG PET: application to focal cerebral ischemia. J. Nucl. Med. 2011, 52(8):1252-1260. (Aug.).
8. Dedeurwaerdere S., Cornelissen B., Van Laere K., Vonck K., Achten E., Slegers G., Boon P. Small animal positron emission tomography during vagus nerve stimulation in rats: a pilot study. Epilepsy Res. 2005, 67(3):133-141. (Dec.).
9. Nguyen V.H., Verdurand M., Dedeurwaerdere S., Wang H., Zahra D., Gregoire M.-C., Zavitsanou K. Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG. Brain Res. Bull. 2012, 87(2):172-179. (Feb.).
10. Schiffer W.K., Mirrione M.M., Dewey S.L. Optimizing experimental protocols for quantitative behavioral imaging with (IF)-I-18-FDG in rodents. J. Nucl. Med. 2007, 48(2):277-287. (Feb.).
11. Hoekstra I., Paglianiti O.S., Hoekstra E.F., Smit P.E., Postmus G.Teule, Lammertsma A.A. Monitoring response to therapy in cancer using [18 F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. Eur. J. Nucl. Med. Mol. I 2000, 27(6):731-743.
12. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann. Neurol. 1979, 6(5):371-388. (Nov.).
13. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 1983, 3(1):1-7. (Mar.).
14. Meijer M.K., Lemmens A.G., Van Zutphen B.F.M., Baumans V. Urinary corticosterone levels in mice in response to intraperitoneal injections with saline. J. Appl. Anim. Welf. Sci. 2005, 8(4):279-283.
15. Alf M.F., Wyss M.T., Buck A., Weber B., Schibli R., Kramer S.D. Quantification of brain glucose metabolism by 18F-FDG PET with real-time arterial and image-derived input function in mice. J. Nucl. Med. 2013, 54(1):132-138. (Jan.).
16. Kemp B.J., Hruska C.B., McFarland A.R., Lenox M.W., Lowe V.J. NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system. Phys. Med. Biol. 2009, 54(8):2359-2376. (Apr.).
17. Kim J., Herrero P., Sharp T., Laforest R., Rowland D.J., Tai Y.C., Lewis J.S., Welch M.J. Minimally invasive method of determining blood input function from PET images in rodents. J. Nucl. Med. 2006, 47(2):330-336. (Feb.).
18. Laforest R., Sharp T.L., Engelbach J.A., Fettig N.M., Herrero P., Kim J., Lewis J.S., Rowland D.J., Tai Y.C., Welch M.J. Measurement of input functions in rodents: challenges and solutions. Nucl. Med. Biol. 2005, 32(7):679-685. (Oct.).
19. Huang S.C., Wu H.M., Shoghi-Jadid K., Stout D.B., Chatziioannou A., Schelbert H.R., Barrio J.R. Investigation of a new input function validation approach for dynamic mouse microPET studies. Mol. Imaging Biol. 2004, 6(1):34-46. (Jan-Feb).
20. Locke L.W., Williams M.B., Fairchild K.D., Zhong M., Kundu B.K., Berr S.S. FDG-PET quantification of lung inflammation with image-derived blood input function in mice. Int. J. Mol. Imaging 2011, 2011:356730.
21. Kudomi N., Bucci M., Oikonen V., Silvennoinen M., Kainulainen H., Nuutila P., Iozzo P., Roivainen A. Extraction of input function from rat [18F]FDG PET images. Mol. Imaging Biol. 2011, 13(6):1241-1249. (Nov.).
22. Hudson H.M., Larkin R.S. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans. Med. Imaging 1994, 13(4):601-609.
23. Kudomi N., Järvisalo M.J., Kiss J., Borra R., Viljanen A., Viljanen T., Savunen T., Knuuti J., Iida H., Nuutila P., Iozzo P. Non-invasive estimation of hepatic glucose uptake from [18F]FDG PET images using tissue-derived input functions. Eur. J. Nucl. Med. Mol. Imaging 2009, 36(12):2014-2026. (Dec.).
24. Defrise M., Kinahan P.E., Townsend D.W., Michel C., Sibomana M., Newport D.F. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans. Med. Imaging 1997, 16(2):145-158.
25. Takikawa S., Dhawan V., Spetsieris P., Robeson W., Chaly T., Dahl R., Margouleff D., Eidelberg D. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993, 188(1):131-136. (Jul.).
26. Watson C.C. New, faster, image-based scatter correction for 3D PET. IEEE Trans. Nucl. Sci. 2000, 47(4):1587-1594.
27. Huang S.C., Phelps M.E., Hoffman E.J., Sideris K., Selin C.J., Kuhl D.E. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am. J. Physiol. Endocrinol. Metab. 1980, 238(1):E69-E82.
28. Schiffer W.K., Mirrione M.M., Biegon A., Alexoff D.L., Patel V., Dewey S.L. Serial microPET measures of the metabolic reaction to a microdialysis probe implant. J. Neurosci. Methods 2006, 155(2):272-284. (Sep.).
29. Littlewood C.L., Cash D., Dixon A.L., Dix S.L., White C.T. Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat. Neuroimage 2006, 32:1733-1746.
30. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J. Nucl. Med. 2009, 50:11S-20S. (May).
31. Dedeurwaerdere S., Wintmolders C., Straetemans R., Pemberton D., Langlois X. Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist. Psychopharmacology 2011, 214(2):505-514. (Mar.).
32. Jan S., Boisgard R., Fontyn Y., Eroukhmanoff C., Comtat C., Trebossen R. Accuracy and variability of quantitative values obtained for mouse imaging using the microPET (R) FOCUS. IEEE Nucl. Sci. Conf. R. 2004, 2934-2937.
33. Dandekar M., Tseng J.R., Gambhir S.S. Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts. J. Nucl. Med. 2007, 48(4):602-607. (Apr.).
34. Toyama H., Ichise M., Liow J.-S., Vines D.C., Seneca N.M., Modell K.J., Seidel J., Green M.V., Innis R.B. Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET. Nucl. Med. Biol. 2004, 31(2):251-256. (Feb.).
35. 18 F-FDG μPET readout of a brain activation model to evaluate the metabotropic Glutamate Receptor 2 Positive Allosteric Modulator JNJ42153605. J. Pharmacol. Exp. Ther. 2014, (submitted for publication).
36. Dedeurwaerdere S., Wintmolders C., Straetemans R., Pemberton D., Langlois X. Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist. Psychopharmacology 2011, 214(2):505-514. (Mar.).
37. Wahl R.L., Henry C.A., Ethier S.P. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992, 183(3):643-647. (Jun.).
38. Hildebrandt I.J., Su H., Weber W.A. Anesthesia and other considerations for in vivo imaging of small animals. Journal 2007, 49:1.
39. Nowland M.H., Hugunin K.M.S., Rogers K.L. Effects of short-term fasting in male Sprague-Dawley rats. Comp. Med. 2011, 61(2):138-144. (Apr.).
40. Shapiro S.S., Wilk M.B. An analysis of variance test for normality. Biometrika 1965, 52:591-611.
41. De Boer S.F., Koopmans S.J., Slangen J.L., Van Der Gugten J. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: effect of interstressor interval length. Physiol. Behav. 1990, 47(6):1117-1124. (Jun.).
42. Pomplun D., Mohlig M., Spranger J., Pfeiffer A., Ristow M. Elevation of blood glucose following anaesthetic treatment in C57Bl/6 mice. Horm. Metab. Res. 2004, 36(1):67-69. (Jan.).
43. Saha J.K., Xia J., Grondin J.M., Engle S.K., Jakubowski J.A. Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp. Biol. Med. 2005, 230(10):777-784.
44. Fueger B.J., Czernin J., Hildebrandt I., Tran C., Halpern B.S., Stout D., Phelps M.E., Weber W.A. Impact of animal handling on the results of 18F-FDG PET studies in mice. J. Nucl. Med. 2006, 47(6):999-1006. (Jun.).
45. Saab B.J., MacLean A.J.B., Kanisek M., Zurek A.A., Martin L.J., Roder J.C., Orser B.A. Short-term memory impairment after isoflurane in mice is prevented by the α5 γ-aminobutyric acid type A receptor inverse agonist L-655,708. Anesthesiology 2010, vol. 113(no. 5):1061.
46. Martic-Kehl M.I., Ametamey S.M., Alf M.F., Schubiger P.A., Honer M. Impact of inherent variability and experimental parameters on the reliability of small animal PET data. EJNMMI Res. 2012, 2(1):1-1. (Jun.).
47. Marsteller D.A., Barbarich-Marsteller N.C., Fowler J.S., Schiffer W.K., Alexoff D.L., Rubins D.J., Dewey S.L. Reproducibility of intraperitoneal 2-deoxy-2-[18F]-fluoro-d-glucose cerebral uptake in rodents through time. Nucl. Med. Biol. 2006, 33(1):71-79. (Jan.).
48. Deleye S., Smits D., Verhaeghe J., wyffels L., Langlois X., Schmidt M., Dedeurwaerdere S., Stroobants S., Staelens S. Protocol optimization to further reduce intra- and interanimal variability in microPET rat brain image quantification. EANM abstract 2012, (Nov.).
49. Hadi M., Bacharach S.L., Whatley M., Libutti S.K., Straus S.E., Rao V.K., Wesley R., Carrasquillo J.A. Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the 'glucose-corrected' SUV. Nucl. Med. Biol. 2008, 35(4):441-445. (May).
50. Huang S.-C. Anatomy of SUV. Nucl. Med. Biol. 2000, 27(7):643-646.